Aviso: para depositar documentos, por favor, inicia sesión e identifícate con tu cuenta de correo institucional de la UCM con el botón MI CUENTA UCM. No emplees la opción AUTENTICACIÓN CON CONTRASEÑA
 

Prevalence of Respiratory Syncytial Virus Infection in Hospitalized COPD Patients in Spain Between 2018–2022

dc.contributor.authorGómez García, Rosa María
dc.contributor.authorMiguel Díez, Javier De
dc.contributor.authorLópez De Andrés, Ana Isabel
dc.contributor.authorHernández Barrera, Valentín
dc.contributor.authorJiménez Sierra, Ana
dc.contributor.authorCuadrado Corrales, María Natividad
dc.contributor.authorZamorano León, José Javier
dc.contributor.authorCarabantes Alarcón, David
dc.contributor.authorBodas Pinedo, Andrés
dc.contributor.authorJiménez García, Rodrigo
dc.date.accessioned2025-02-07T11:13:14Z
dc.date.available2025-02-07T11:13:14Z
dc.date.issued2025-01-20
dc.description.abstractBackground: Respiratory syncytial virus (RSV) infection is a common cause of hospital admission. The association between chronic obstructive pulmonary disease (COPD) exacerbation and RSV infection is not well studied. Objective: To analyze the hospitalizations of patients with COPD and RSV infection in Spain between 2018 and 2022. Methods: The data used were obtained from the Spanish Hospital Discharge Database. We selected subjects aged >= 40 years diagnosed with COPD, admitted to the hospital from 1 January 2018 to 31 December 2022. The COPD population that met the selection criteria was subdivided based on the presence of an ICD-10 code for RSV infection. To obtain comparable populations, for each subject with COPD and RSV infection, a subject without an RSV code was selected, with the COPD code in the same diagnostic position (1 to 20), as well as the same year of admission, sex, and age. Results: Among subjects aged >= 40 years, 1,429,288 were identified as having COPD, of whom 5673 also had RSV infection. The number of hospitalizations with COPD and RSV infection increased during the study period. The proportion of RSV infection among patients admitted for COPD increased significantly over time, from 0.32% in 2018 to 0.65% in 2022, p < 0.001. In-hospital mortality (IHM) increased over time, but the differences were not significant (6.23% in 2018 vs. 6.79% in 2022). Patients with COPD and RSV infection had, compared with those without RSV infection, a higher use of mechanical ventilation, both invasive (3.44% vs. 1.34%, p < 0.001) and noninvasive (8.09% vs. 4.51%, p < 0.001) and a higher proportion of intensive care unit (ICU) admission (7.21% vs. 3.9%, p < 0.001). After multivariate adjustment, a significant increase in IHM was found from 2018 to 2022 in subjects with and without RSV infection. The presence of RSV infection was associated with a higher mortality (OR 1.22; 95% CI 1.01-1.46). Conclusions: The proportion of RSV infection among patients admitted for COPD increased significantly over time. Patients with COPD and RSV infection had, compared with those without RSV infection, a higher severity, a higher use of mechanical ventilation, and a higher proportion of ICU admission. The presence of RSV infection was associated with IHM. These results can help to identify patients at higher risk and make decisions to avoid the increased risk of hospitalization and mortality in this population.
dc.description.departmentDepto. de Salud Pública y Materno - Infantil
dc.description.facultyFac. de Medicina
dc.description.refereedTRUE
dc.description.sponsorshipSociedad Espanola de Neumologia y Cirugia de Torax
dc.description.sponsorshipUniversidad Complutense de Madrid
dc.description.sponsorshipSociedad Madrilena de Neumologia y Cirugia de Torax
dc.description.sponsorshipComunidad Autónoma de Madrid
dc.description.statuspub
dc.identifier.citationGómez-García RM, De-Miguel-Díez J, López-de-Andrés A, Hernández-Barrera V, Jimenez-Sierra A, Cuadrado-Corrales N, Zamorano-León JJ, Carabantes-Alarcón D, Bodas-Pinedo A, Jiménez-García R. Prevalence of Respiratory Syncytial Virus Infection in Hospitalized COPD Patients in Spain Between 2018-2022. Diseases. 2025 Jan 20;13(1):23
dc.identifier.doi10.3390/diseases13010023
dc.identifier.essn2079-9721
dc.identifier.officialurlhttps://doi.org/10.3390/diseases13010023
dc.identifier.pmid39851487
dc.identifier.relatedurlhttps://www.mdpi.com/2079-9721/13/1/23
dc.identifier.relatedurlhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11764113/
dc.identifier.urihttps://hdl.handle.net/20.500.14352/117907
dc.issue.number1
dc.journal.titleDISEASES
dc.language.isoeng
dc.publisherMPDI
dc.rightsAttribution 4.0 Internationalen
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject.cdu614
dc.subject.keywordCOPD
dc.subject.keywordRespiratory syncytial virus
dc.subject.keywordMortality
dc.subject.keywordSpain
dc.subject.ucmCiencias Biomédicas
dc.subject.unesco32 Ciencias Médicas
dc.titlePrevalence of Respiratory Syncytial Virus Infection in Hospitalized COPD Patients in Spain Between 2018–2022
dc.typejournal article
dc.type.hasVersionVoR
dc.volume.number13
dspace.entity.typePublication
relation.isAuthorOfPublication272b1d1a-b87e-452e-841a-fb423b49b163
relation.isAuthorOfPublication64f8e9e8-c868-4928-9d82-147712d9fb81
relation.isAuthorOfPublicationbb8f878b-0381-4670-bae4-309bee96effb
relation.isAuthorOfPublication87c0e499-ccfa-49e0-93aa-b26aef373c89
relation.isAuthorOfPublication0de35c8b-4b4c-4920-9225-94e4cf4dfb1f
relation.isAuthorOfPublication905af5c7-75ed-4e1a-a643-3cc365b6b809
relation.isAuthorOfPublication5db1f21a-0369-4191-96f5-b640ed0f3dde
relation.isAuthorOfPublication.latestForDiscovery272b1d1a-b87e-452e-841a-fb423b49b163

Download

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Prevalence_of_Respiratory_Sync.pdf
Size:
278.25 KB
Format:
Adobe Portable Document Format

Collections